Translational research

Translational research projects encourage collaborations between basic and clinical research. Their goal is to study cells and their interactions with the environment, and in so doing to provide new impulses for novel therapies and clinical approaches in order to be able to act on the causes of cellular malfunction.  

Financial support for translational cancer research projects is possible thanks to:

"Allocated funds" - These funds are specifically created for each project. They come from private donations and must be used for the predetermined purpose. The Foundation guarantees that donations are used in full to finance the project to which they have been allocated.

“ISREC chairs” - These are created to offer young professors affiliated to the EPFL (School of Life Sciences - ISREC) or to a Swiss University (Faculty of biology or medicine) the opportunity to launch their career in research. They are financed by the fortune of the Foundation.

Translational research - ongoing projects

Personalized immunotherapy

This “allocated fund” from the Biltema Foundation was granted in July 2016 for 3 years.

Research laboratory of Prof. George Coukos (CHUV/UNIL/LICR)

More information

Development of antibody therapies for solid tumors and acute myeloid leukemia

This “allocated fund” from the Biltema Foundation was granted in July 2016 for 3 years.

Research laboratories of Prof. Carl Borrebaeck and Prof....

More information

Breast cancer

This “allocated fund” from the Biltema Foundation was granted in July 2016 for 3 years.

Research laboratories of Prof. Ake Borg (Lund University,...

More information

News & Events

Posted on

The Swiss Institute for Experimental Cancer Research was established 55 years ago in Lausanne. A dream formulated in those days has now come true: the...

Read more
Posted on

See our Annual Report 2018!

Read more
Posted on

The ISREC Foundation supports 6 students within the scope of the “Summer Research Program for Undergraduate Students” – EPFL School of Life Sciences,...

Read more
Posted on

Congratulations to Professors Ho and Girault for their discovery, a breakthrough that opens up new possibilities for the use of the cancer...

Read more